alrestatin and tolrestat

alrestatin has been researched along with tolrestat in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (40.00)	18.7374
1990's	3 (60.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abraham, N; Bellini, F; Dvornik, D; Fung, S; Humber, L; Sestanj, K; Simard-Duquesne, N; Treasurywala, A	1
Ansari, NH; Bhatnagar, A; Das, B; Liu, SQ; Srivastava, SK	1
Humber, LG	1
Burnakis, TG; Tsai, SC	1
Gelber, DA; Pfeifer, MA; Schumer, MP	1

Reviews

3 review(s) available for alrestatin and tolrestat

Article	Year
The medicinal chemistry of aldose reductase inhibitors. Progress in medicinal chemistry, 1987, Volume: 24 Topics: Aldehyde Reductase; Animals; Flavonoids; Humans; Hydantoins; Isoquinolines; Naphthalenes; Sugar Alcohol Dehydrogenases	1987
Aldose reductase inhibitors: an update. The Annals of pharmacotherapy, 1993, Volume: 27, Issue:6 Topics: Aldehyde Reductase; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Humans; Imidazoles; Imidazolidines; Isoquinolines; Naphthalenes; Phthalazines	1993
Aldose reductase inhibitors: the end of an era or the need for different trial designs? Diabetes, 1997, Volume: 46 Suppl 2 Topics: Aldehyde Reductase; Autonomic Nervous System; Diabetic Neuropathies; Enzyme Inhibitors; Humans; Imidazoles; Imidazolidines; Isoquinolines; Naphthalenes; Phthalazines; Time Factors	1997

Trials

1 trial(s) available for alrestatin and tolrestat

Article	Year
Aldose reductase inhibitors: the end of an era or the need for different trial designs? Diabetes, 1997, Volume: 46 Suppl 2 Topics: Aldehyde Reductase; Autonomic Nervous System; Diabetic Neuropathies; Enzyme Inhibitors; Humans; Imidazoles; Imidazolidines; Isoquinolines; Naphthalenes; Phthalazines; Time Factors	1997

Other Studies

2 other study(ies) available for alrestatin and tolrestat

Article	Year
N-[5-(trifluoromethyl)-6-methoxy-1-naphthalenyl]thioxomethyl]- N-methylglycine (Tolrestat), a potent, orally active aldose reductase inhibitor. Journal of medicinal chemistry, 1984, Volume: 27, Issue:3 Topics: Aldehyde Reductase; Animals; Cattle; Diabetes Mellitus, Experimental; Galactitol; Isoquinolines; Lens, Crystalline; Naphthalenes; Rats; Sorbitol; Sugar Alcohol Dehydrogenases	1984
Inhibition kinetics of human kidney aldose and aldehyde reductases by aldose reductase inhibitors. Biochemical pharmacology, 1990, Mar-15, Volume: 39, Issue:6 Topics: Aldehyde Reductase; Aldehydes; Carbohydrate Dehydrogenases; Chromones; Humans; Imidazoles; Imidazolidines; Isoquinolines; Kidney; Kinetics; Naphthalenes; Phenobarbital; Phthalazines; Quercetin; Quinolones; Substrate Specificity; Sugar Alcohol Dehydrogenases	1990

Article

Year

N-[5-(trifluoromethyl)-6-methoxy-1-naphthalenyl]thioxomethyl]- N-methylglycine (Tolrestat), a potent, orally active aldose reductase inhibitor.

Journal of medicinal chemistry, 1984, Volume: 27, Issue:3

Topics: Aldehyde Reductase; Animals; Cattle; Diabetes Mellitus, Experimental; Galactitol; Isoquinolines; Lens, Crystalline; Naphthalenes; Rats; Sorbitol; Sugar Alcohol Dehydrogenases

1984

Inhibition kinetics of human kidney aldose and aldehyde reductases by aldose reductase inhibitors.

Biochemical pharmacology, 1990, Mar-15, Volume: 39, Issue:6

Topics: Aldehyde Reductase; Aldehydes; Carbohydrate Dehydrogenases; Chromones; Humans; Imidazoles; Imidazolidines; Isoquinolines; Kidney; Kinetics; Naphthalenes; Phenobarbital; Phthalazines; Quercetin; Quinolones; Substrate Specificity; Sugar Alcohol Dehydrogenases

1990